The ocular hypertensive effects of topical 0.1% dexamethasone in beagles with inherited glaucoma.
Topical 0.1% dexamethasone(50 microl) instilled QID in glaucomatous Beagles increased intraocular pressure (IOP) by about 5 mm Hg within the first seven to ten days in a four week test. The elevated levels of IOP persisted until drug instillations ceased. Both drug eye and placebo eye IOP levels were increased significantly over the predrug (control) IOPs. Comparisons of the IOP changes associated with topical dexamethasone in beagles bred for glaucoma and less than seven months of age to older glaucomatous Beagles did not detect any significant differences. The magnitude of elevation in IOP in both age groups was about 4.8 mmHg. During the week after cessation of the topical dexamethasone instillations, IOPs of both the drug and placebo eyes declined toward predrug levels. Primary open angle glaucoma in the Beagle exhibits a significant and rapid elevation in IOP following unilateral or bilateral 0.1% dexamethasone instilled QID.
Gelatt
K N
KN
Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville 32610-0126, USA.
Mackay
E O
EO
D000287:Administration, Topical; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D003907:Dexamethasone / Q000009:adverse effects*; D004283:Dog Diseases / Q000139:chemically induced*; D004285:Dogs; D005123:Eye / Q000187:drug effects* / Q000503:physiopathology; D005260:Female; D005901:Glaucoma / Q000235:genetics / Q000662:veterinary*; D005938:Glucocorticoids; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D009798:Ocular Hypertension / Q000139:chemically induced / Q000662:veterinary*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D003907:Dexamethasone